Search Results
DDx Strength: Weak
durvalumab, Rash or multiple lesions, 50-59 year old Female

Edit Findings
Cutaneous adverse effects of immune checkpoint inhibitors
Immune checkpoint inhibitor-related adverse effects
Exanthematous drug eruptionExanthematous drug eruption
PsoriasisPsoriasis
XerosisXerosis
Drug-induced hepatotoxicity
Pruritus without rashPruritus without rash
Bullous drug eruption
Drug-induced thrombocytopenia
Bacterial sepsisBacterial sepsis
Lichenoid drug eruptionLichenoid drug eruption
SarcoidosisSarcoidosis
Sjögren syndromeSjögren syndrome
Bullous pemphigoidBullous pemphigoid
Polymyalgia rheumatica
Eosinophilic fasciitisEosinophilic fasciitis
Immunoglobulin A vasculitisImmunoglobulin A vasculitis
Raynaud phenomenonRaynaud phenomenon
VitiligoVitiligo
Granuloma annulareGranuloma annulare
VasculitisVasculitis
DermatomyositisDermatomyositis
Drug-induced oral mucositis
Drug-induced abdominal pain
Drug-induced cough
Drug-induced diarrhea
Drug-induced nausea or vomiting
HypothyroidismHypothyroidism
Acute kidney injury
Colitis
Diabetic ketoacidosis
Drug-induced anorexia
Drug-induced arthralgia
Drug-induced constipation
Drug-induced dyspnea
Drug-induced fatigue
Drug-induced fever
Drug-induced leukopenia
Drug-induced myopathies
Gastritis
Hyperthyroidism
Hypokalemia
Hyponatremia
Ocular drug reaction
Peripheral neuropathy
Pulmonary embolismPulmonary embolism
Secondary adrenal insufficiency
Bowel perforationBowel perforation
Drug-induced diabetes
Drug-induced hyperlipasemia
Drug-induced pneumonitis
Drug-induced weakness
Hypopituitarism
Myocarditis
Radiation pneumonitis
ThyroiditisThyroiditis
Drug-induced anemia
Drug-induced hyperamylasemia
DehydrationDehydration
Urinary tract infection